Hospira, Inc. (Hospira), is a specialty pharmaceutical and medication delivery company that develops, manufactures and markets products. Hospira's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems. Hospira's portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. Hospira conducts operations globally and is managed in three segments: Americas, Europe, Middle East and Africa (EMEA) and Asia Pacific (APAC). In October 2009, Halcygen Pharmaceuticals Limited announced that it completed the acquisition of Mayne Pharma International Pty Ltd (MPI) from Hospira Australia Pty Ltd, a wholly owned subsidiary of the Company.